YWHAE antibody (AA 1-255) (Biotin)
Quick Overview for YWHAE antibody (AA 1-255) (Biotin) (ABIN7142088)
Target
See all YWHAE AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-255
-
Cross-Reactivity
- Human
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human 14-3-3 protein epsilon protein (1-255AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- YWHAE (14-3-3 epsilon (YWHAE))
-
Alternative Name
- YWHAE
-
Background
-
Background: Adapter protein implicated in the regulation of a large spectrum of both general and specialized signaling pathways. Binds to a large number of partners, usually by recognition of a phosphoserine or phosphothreonine motif. Binding generally results in the modulation of the activity of the binding partner.
Aliases: 14 3 3 E antibody, 14 3 3 epsilon antibody, 14 3 3E antibody, 14-3-3 protein epsilon antibody, 14-3-3E antibody, 1433E_HUMAN antibody, Epididymis luminal protein 2 antibody, FLJ45465 antibody, FLJ53559 antibody, HEL2 antibody, KCIP 1 antibody, KCIP1 antibody, MDCR antibody, MDS antibody, Mitochondrial import stimulation factor L subunit antibody, Protein kinase C inhibitor protein1 antibody, Tyrosine 3 monooxygenase/tryptophan 5 monooxygenase activation protein, epsilon antibody, Tyrosine 3 monooxygenase/tryptophan 5 monooxygenase activation protein, epsilon polypeptide antibody, Tyrosine 3/tryptophan 5 monooxygenase activation protein epsilon polypeptide antibody, YWHAE antibody
-
UniProt
- P62258
-
Pathways
- Neurotrophin Signaling Pathway, Myometrial Relaxation and Contraction, M Phase
Target
-